Skip to main content
Microbiology logoLink to Microbiology
. 2022 Mar 25;168(3):001164. doi: 10.1099/mic.0.001164

Exposure to the Pseudomonas aeruginosa secretome alters the proteome and secondary metabolite production of Aspergillus fumigatus

Anatte Margalit 1, David Sheehan 1, James C Carolan 1, Kevin Kavanagh *
PMCID: PMC9558348  PMID: 35333152

Abstract

The fungal pathogen Aspergillus fumigatus is frequently cultured from the sputum of cystic fibrosis (CF) patients along with the bacterium Pseudomonas aeruginosa. A. fumigatus secretes a range of secondary metabolites, and one of these, gliotoxin, has inhibitory effects on the host immune response. The effect of P. aeruginosa culture filtrate (CuF) on fungal growth and gliotoxin production was investigated. Exposure of A. fumigatus hyphae to P. aeruginosa cells induced increased production of gliotoxin and a decrease in fungal growth. In contrast, exposure of A. fumigatus hyphae to P. aeruginosa CuF led to increased growth and decreased gliotoxin production. Quantitative proteomic analysis was used to characterize the proteomic response of A. fumigatus upon exposure to P. aeruginosa CuF. Changes in the profile of proteins involved in secondary metabolite biosynthesis (e.g. gliotoxin, fumagillin, pseurotin A), and changes to the abundance of proteins involved in oxidative stress (e.g. formate dehydrogenase) and detoxification (e.g. thioredoxin reductase) were observed, indicating that the bacterial secretome had a profound effect on the fungal proteome. Alterations in the abundance of proteins involved in detoxification and oxidative stress highlight the ability of A. fumigatus to differentially regulate protein synthesis in response to environmental stresses imposed by competitors such as P. aeruginosa . Such responses may ultimately have serious detrimental effects on the host.

Keywords: Aspergillus, gliotoxin, infection, Pseudomonas, proteomics

Introduction

Aspergillus fumigatus is a ubiquitous saprophytic mould that releases airborne conidia, which may enter the human respiratory tract through inhalation. Many of the biological determinants that contribute to the ubiquity of the fungus in nature also play a role in establishing disease in humans and are associated with virulence and pathogenesis [1–6]. Among these attributes are the wide range of biosynthetic gene clusters (>30) responsible for the production of secondary metabolites that confer advantages to A. fumigatus in its natural habitat, including protection against UV stress, desiccation and competition with other microorganisms [7–9]. Some of these secondary metabolites may play a role in evading or subverting the host immune response in vivo, and consequently many secondary metabolites such as gliotoxin, fumagillin and dihydroxynapthalene (DHN) melanin, and their effects on the host, have been well characterized [7, 9–12].

A. fumigatus is frequently detected in the airways of individuals with cystic fibrosis (CF) from an early age and contributes to the structural damage and disease progression [13–15]. Allergic bronchopulmonary aspergillosis (ABPA) is a hypersensitivity disorder characterized by the induction of a pro-inflammatory immune response triggered by the secretion of fungal toxins and allergens in the airways. It is estimated that 1–2.5 % of patients with persistent asthma and 1–15 % of CF patients are affected by ABPA [16–18], but this prevalence has probably been underestimated due to under-diagnosis [19].

The most common bacterial pathogen associated with CF, Pseudomonas aeruginosa , is a major cause of morbidity and mortality and it is estimated that 60–80 % of CF patients experience chronic P. aeruginosa infection by the age of 20 years [20–22]. A. fumigatus infection is associated with an increased risk of P. aeruginosa infection and co-infection is associated with a decline in lung function [14, 21, 23, 24]. The prevalence of co-colonization with P. aeruginosa and A. fumigatus in the CF airways is estimated to be between 3.1 and 15.8 %, although this occurrence may be higher [20, 25, 26].

Co-infection studies have demonstrated that P. aeruginosa may inhibit A. fumigatus growth in vivo and in vitro [27–32]. Indirect interaction studies have shown that gliotoxin, produced by A. fumigatus, inhibits P. aeruginosa growth [33]. However, there is evidence to show that under nutrient-limiting conditions, A. fumigatus creates a nutrient-rich environment in which P. aeruginosa can rapidly proliferate [34]. A number of studies have been performed to show the effect of volatile organic compounds (VOCs) produced by P. aeruginosa on A. fumigatus growth [35–37]. The studies revealed contrasting results whereby P. aeruginosa -derived sulphur-based VOCs, such as dimethyl sulphide, promote A. fumigatus growth [35], while another class of ketone-based VOCs inhibit fungal growth [37]. Differences in growth media, bacterial strains and experimental design probably contribute to the production of different VOCs, explaining the contrasting results of these studies [37]. Nevertheless, the manner in which one pathogen impacts the metabolome of another may have serious implications for the host, as competition between microorganisms can often lead to an altered secretion profile that can have the potential to increase damage to host tissue [38, 39].

Although numerous interaction studies have been performed between these pathogens, the influence of the P. aeruginosa secretome on the A. fumigatus proteome and secondary metabolite production has not been fully characterized to date. In this study, label-free quantitative MS was used to investigate how A. fumigatus responds to P. aeruginosa culture filtrate (CuF) produced under nutrient-limiting, nitrate-rich conditions. Understanding the interactions that occur between these pathogens is vital to the development of therapeutic targets that will minimize the contribution of these pathogens, individually and collectively, to disease progression.

Methods

Pseudomonas aeruginosa cultures

P. aeruginosa (PAO1) was cultivated on nutrient agar (Oxoid) or in nutrient broth (Oxoid) at 37 °C. Bacterial cultures were grown to stationary phase (48 h) at 37 °C in an orbital incubator (200 r.p.m.). The concentration of the bacterial suspension was measured by obtaining the optical density at 600 nm (OD600), and an OD of 1 equated to 3×108 c.f.u. ml−1.

Aspergillus fumigatus cultures

A. fumigatus (ATCC 26933) was grown on Sabouraud dextrose agar (Oxoid) at 37 °C. Conidia were harvested using 0.01 % (v/v) Tween-80 and washed twice with PBS. Conidial density was ascertained by haemocytometry and conidia were added to Czapek-Dox liquid media to give a density of 5×105 ml−1. The cultures were incubated for 48 h at 37 °C in an orbital incubator at 200 r.p.m.

Preparation of P. aeruginosa culture filtrates

Czapek-Dox liquid media (pH 6.8) (Duchefa, Biochemi) was inoculated with P. aeruginosa and incubated for 48 h at 37 °C in an orbital incubator, at 200 r.p.m. The bacteria were harvested by centrifugation (15 min, 2000  g ). P. aeruginosa CuF was sterilized using 0.2 µm filtropur S filters (Sarstedt) and the pH was measured (pH 7.2).

Preparation of A. fumigatus culture filtrate

A. fumigatus conidia (5×105 ml−1) were added to Czapek-Dox liquid media (pH 6.8). The cultures were incubated for 48 h at 37 °C in an orbital incubator at 200 r.p.m. The hyphal mass was harvested and the wet weight was recorded. The A. fumigatus CuF was sterilized using 0.2 µm filtropur S filters (Sarstedt) and the pH was measured (4.5).

Exposure of A. fumigatus to culture filtrates

A. fumigatus conidia (5×105 conidia ml–1 in 25 ml Czapek-Dox liquid media) were cultured for 4 h in Czapek-Dox liquid media until germination occurred (verified microscopically). A. fumigatus CuF or P. aeruginosa CuF (50 ml) were added to the fungal cultures (n=4) to give a final volume of 75 ml (66 % CuF to 33 % starting culture). The fungal cultures were incubated for 24 h at 37 °C in an orbital incubator (200 r.p.m.).

Extraction of gliotoxin from P. aeruginosa -exposed and CuF-exposed A. fumigatus cultures

Filtrates obtained from A. fumigatus cultures that had been exposed to various concentrations of P. aeruginosa , A. fumigatus or P. aeruginosa CuF (n=4) were mixed with an equal volume (20 ml) of chloroform (Fisher Chemical) for 2 h at room temperature. The chloroform fraction was collected and dried by rotary evaporation in a Büchi rotor evaporator (Brinkmann Instruments). Dried extracts were dissolved in 500 µl methanol (Fisher Chemical) and stored at −20 °C.

Quantification of gliotoxin by RP-HPLC

Gliotoxin was detected by reversed phase-HPLC (RP-HPLC; Shimadzu). The mobile phase was 34.9 % (v/v) acetonitrile (Fisher Scientific), 0.1 % (v/v) trifluoroacetic acid (TFA) (Sigma Aldrich) and 65 % (v/v) HPLC-grade water (ddH2O). Gliotoxin extract (20 µl) (Sigma Aldrich) was injected onto a Lunar Omega, 5 µm polar C18, LC column (Phenomenex). A standard curve of peak area versus gliotoxin concentration was constructed using gliotoxin standards (0.1, 0.25, 0.5 and 1.0 µg per 10 µl) dissolved in methanol (Sigma Aldrich).

Protein extraction from A. fumigatus hyphae

A. fumigatus hyphae from each CuF-exposed treatment (n=4) were crushed to a fine dust with liquid nitrogen in a mortar using a pestle. Lysis buffer (4 ml g−1 hyphae) [8 M urea, 2 M thiourea, and 0.1 M Tris-HCl (pH 8.0) dissolved in HPLC-grade dH2O], supplemented with protease inhibitors [aprotinin, leupeptin, pepstatin A, and Tosyllysine Chloromethyl Ketone hydrochloride (TLCK) (10 µg ml−1) and PMSF (1 mM ml−1)] was added to the crushed hyphae. Cell lysates were sonicated (Bendelin Senopuls), three times for 10 s at 50 % power. The cell lysate was subjected to centrifugation (Eppendorf Centrifuge 5418) for 8 min at 14 500  g to pellet cellular debris. The supernatant was removed and quantified using the Bradford method. Samples (100 µg) were subjected to overnight acetone precipitation.

Label-free MS (LF/MS)

A. fumigatus proteins were pelleted by centrifugation for 10 min at 14 500  g . The acetone was removed and the protein pellet was re-suspended in 25 µl sample resuspension buffer [8 M urea, 2 M thiourea, 0.1 M Tris-HCl (pH 8.0) dissolved in HPLC-grade dH2O]. An aliquot (2 µl) was removed from each sample and quantified using the Qubit quantification system (Invitrogen), following the manufacturer’s instructions. Ammonium bicarbonate (125 µl, 50 mM) was added to the remaining 20 µl of each sample. The protein sample was reduced by adding 1 µl 0.5 M DTT and incubated at 56 °C for 20 min, followed by alkylation with 0.55 M iodoacetamide at room temperature, in the dark for 15 min. Protease Max Surfactant Trypsin Enhancer (Promega) (1 µl, 1 % w/v) and Sequence Grade Trypsin (Promega) (0.5 µg µl−1) was added to the proteins and incubated at 37 °C for 18 h. Digestion was terminated by adding TFA (1 µl, 100 %) to each tryptic digest sample, and incubated at room temperature for 5 min. Samples were centrifuged for 10 min at 14 500  g and purified for MS using C18 Spin Columns (Pierce), following the manufacturer’s instructions. The eluted peptides were dried using a SpeedyVac concentrator (Thermo Scientific Savant DNA120) and resuspended in 2 % (v/v) acetonitrile and 0.05 % (v/v) TFA to give a final peptide concentration of 1 µg µl−1. The samples were sonicated for 5 min to aid peptide resuspension, followed by centrifugation for 5 min at 14 500  g . The supernatant was removed and used for MS. Three independent biological replicates for each group were analysed in this study.

Protein extraction from P. aeruginosa culture filtrates

Aliquots of P. aeruginosa culture filtrates were subjected to overnight acetone precipitation. Precipitated proteins were pooled together and resuspened with lysis buffer (total 250 µl) containing protease inhibitors as described above. An aliquot (2 µl) was removed from the lysate and quantified using the Qubit quantification system (Invitrogen). Samples (50 µg) were subjected to a further overnight acetone precipitation step and prepared for analysis by LC-MS as described above.

MS: LC/MS Xcalibur Instrument parameters for A. fumigatus proteomic data acquisition

Each digested A. fumigatus protein sample (750 ng) and P. aeruginosa CuF sample (500 ng) was loaded onto a QExactive (ThermoFisher Scientific) high-resolution accurate MS device connected to a Dionex Ultimate 3000 (RSLCnano) chromatography system. Peptides were separated by an increasing acetonitrile gradient on a 50 cm EASY-Spray PepMap C18 column of 75 µm diameter (2 µm particle size), using a 133 min (A. fumigatus proteins) and 65 min ( P. aeruginosa CuF proteins) reversed-phase gradient at a flow rate of 300 nl min−1. All data were acquired with the MS device operating in an automatic-dependent switching mode. A full MS scan at 70 000 resolution and a range of 400–1600 m/z was followed by an MS/MS scan at 17 500 resolution, with a range of 200–2000 m/z to select the 15 most intense ions prior to MS/MS.

Quantitative analysis (protein quantification and LFQ normalization of the MS/MS data) of the A. fumigatus proteome arising from exposure to the different CuFs was performed using MaxQuant version 1.5.3.3 (http://www.maxquant.org) following the general procedures and settings outlined previously [40]. The Andromeda search algorithm incorporated in the MaxQuant software was used to correlate MS/MS data against the Uniprot-SWISS-PROT database for A. fumigatus Af293 (downloaded 11 September 2018; 9648 entries). The following search parameters were used: first search peptide tolerance of 20 ppm, second search peptide tolerance of 4.5 ppm with cysteine carbamidomethylation as a fixed modification and N-acetylation of protein and oxidation of methionine as variable modifications and a maximum of two missed cleavage sites allowed. The false discovery rate (FDR) was set to 1 % for both peptides and proteins, and the FDR was estimated following searches against a target-decoy database. Peptides with minimum length of 7 aa were considered for identification and proteins were only considered identified when observed in three replicates of one sample group.

Data analysis of the A. fumigatus proteome

Perseus v.1.5.5.3 (www.maxquant.org/) was used for data analysis, processing and visualization. Normalized LFQ intensity values were used as the quantitative measurement of protein abundance for subsequent analysis. The data matrix was first filtered to remove contaminants and peptides identified by site. LFQ intensity values were log2-transformed and each sample was assigned to its corresponding group, i.e. A. fumigatus exposed to A. fumigatus CuF versus P. aeruginosa CuF. Proteins not found in three out of three replicates in at least one group were omitted from the analysis. A data-imputation step was conducted to replace missing values with values that simulate signals of low-abundance proteins chosen randomly from a distribution specified by a downshift of 1.8 times the mean standard deviation (sd) of all measured values and a width of 0.3 times this sd. Normalized intensity values were used for a principal component analysis (PCA). Exclusively expressed proteins (those that were uniquely expressed or completely absent in one group) were identified from the pre-imputation dataset and included in subsequent analyses. Gene ontology (GO) mapping was also performed in Perseus using the UniProt gene ID for all identified proteins to query the Perseus annotation file (downloaded September 2018) and extract terms for biological process, molecular function and Kyoto Encyclopaedia of Genes and Genomes (KEGG) name.

To visualize differences between two samples, pairwise Student’s t-tests were performed for all using a cut-off of P<0.05 on the post-imputated dataset. Volcano plots were generated in Perseus by plotting negative log P-values on the y-axis and log2 fold-change values on the x-axis for each pairwise comparison. The ‘categories’ function in Perseus was utilized to highlight and visualize the distribution of various pathways and processes on selected volcano plots. Statistically significant (ANOVA, P<0.05) and differentially abundant proteins [statistically significant differentially abundant (SSDA)], i.e. with fold change of plus or minus 1.5, were chosen for further analysis.

The MS proteomics data and MaxQuant search output files have been deposited with the ProteomeXchange Consortium [41] via the PRIDE partner repository with the dataset identifier PXD030171.

Data analysis of the P. aeruginosa CuF secretome

Qualitative analysis of the proteome arising from the P. aeruginosa CuF was investigated using Proteome Discoverer 1.4 and Sequest HT (SEQUEST HT algorithm; Thermo Scientific). Identified proteins were searched against the UniProtKB database ( Pseudomonas aeruginosa ; 5564 entries). Search parameters applied for protein identification were as follows: (i) enzyme name – trypsin, (ii) an allowance of up to two missed cleavages, (iii) peptide mass tolerance set to 10 ppm, (iv) MS/MS mass tolerance set to 0.02 Da, (v) carbamidomethylation set as a fixed modification and (vi) methionine oxidation set as a variable modification . Peptide probability was set to high confidence (with an FDR≤0.01 % as determined by Percolator validation in Proteome Discoverer). Peptides with a minimum score of two and fewer than two unique peptides were excluded from further analysis [42]. The MS proteomics data and Proteome Discoverer search output files have been deposited with the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD031565.

Statistical analysis

The effect of P. aeruginosa on A. fumigatus growth was analysed using GraphPad Prism 5. One-way ANOVA with Tukey’s multiple comparisons test was performed to compare the growth of hyphae exposed to different bacterial densities and CuFs, and the effect on gliotoxin production. P values <0.05 were considered significant.

Results

Analysis of the effect of P. aeruginosa on A. fumigatus growth and gliotoxin production

The addition of P. aeruginosa cells to a culture of ungerminated conidia inhibited the growth of A. fumigatus, and as such, data could not be obtained to examine the P. aeruginosa–A. fumigatus interaction. To measure the effect of P. aeruginosa cells on A. fumigatus growth, different concentrations of P. aeruginosa (1 ml OD 1.0, which equates to approximately 3×108 cells ml−1, OD 0.5 and OD 0.1) were added to established (48 h) A. fumigatus cultures grown in Czapek-Dox medium (100 ml). The co-cultures were incubated for 24 h after which the effect on fungal growth was measured by obtaining the wet weight of the hyphae (Fig. 1a). Gliotoxin was extracted from each group of bacteria-exposed A. fumigatus cultures and quantified by RP-HPLC (Fig. 1b). The decrease in wet weight and an increase in gliotoxin production correlated with the increase in P. aeruginosa cell density. The wet weights of fungal cultures exposed to the highest concentration of P. aeruginosa (OD 1) (9.1±0.3 mg ml−1) were 46 % lower than the controls (16.7±3.1 mg ml−1). The level of gliotoxin produced by A. fumigatus exposed to these bacterial densities was 2.82±0.3 µg mg−1. In contrast, the level of gliotoxin produced by the control cultures was three-fold lower (0.96±0.03 µg mg−1).

Fig. 1.

Fig. 1.

The effect of P. aeruginosa cells on A. fumigatus hyphal growth and gliotoxin production. (a) A. fumigatus hyphae (wet weight mg ml−1) after co-incubation for 24 h with nutrient broth (control, 1 ml) or P. aeruginosa cell suspension (OD600 0.1, 0.5, 1.0; 1 ml). (b) Gliotoxin (µg mg−1 hyphae) produced by A. fumigatus in Czapek-Dox liquid media supplemented with nutrient broth (control, 1 ml) or P. aeruginosa cell suspension (OD600 0.1, 0.5, 1.0; 1 ml) measured by RP-HPLC. ***P<0.001, **P<0.01, *P<0.05, ns: non-significant.

To investigate the effect of the P. aeruginosa secretome on growth of A. fumigatus, conidia were allowed to germinate in Czapek-Dox liquid media for 4 h, and then supplemented with the culture filtrate produced by P. aeruginosa grown in Czapek-Dox for 48 h ( P. aeruginosa CuF). A. fumigatus growth was greater after exposure to P. aeruginosa CuF (6.93±0.25 mg ml−1) compared to growth in A. fumigatus CuF (3.5±0.21 mg ml−1) or non-supplemented media (2.58±0.05 mg ml−1) (Fig. 2). The highest concentrations of gliotoxin were detected in the supernatants of the fungal cultures exposed to A. fumigatus CuF (2.1±0.27 µg mg−1 hyphae) followed by those exposed to non-supplemented media (0.88±0.027 µg mg−1 hyphae) and P. aeruginosa CuF (0.24±0.07 µg mg−1 hyphae), respectively (Fig. 2).

Fig. 2.

Fig. 2.

The effect of P. aeruginosa CuF on early stages of A. fumigatus growth and gliotoxin production. A. fumigatus germinating conidia grown in Czapek-Dox media for 4 h prior to exposure to non-supplemented media (sterile Czapek-Dox), A. fumigatus CuF or P. aeruginosa CuF for 24 h. Fungal growth was measured as wet weight (mg ml−1). Gliotoxin (µg ml−1) was extracted from fungal cultures after 24 h and measured by RP-HPLC ***P<0.001, **P<0.01.

To investigate whether the differences in fungal growth were caused by differences in pH of the A. fumigatus and P. aeruginosa secretome, the pH of the CuFs was determined. The pH of sterile Czapek-Dox medium was adjusted to that of the A. fumigatus secretome (pH 4.5) and P. aeruginosa secretome (pH 7.2). Conidia were cultured for 4 h as described previously prior to being exposed to the pH-adjusted Czapek-Dox medium. The pH and the wet weight of the fungus were measured after 24 h (Fig. S1, available in the online version of this article), and indicate that pH did not affect the growth of A. fumigatus.

Analysis of the P. aeruginosa secretome by MS

The protein content of the culture filtrates produced by P. aeruginosa was analysed by high-resolution MS. In total, 402 proteins were detected, of which 134 remained after filtering. The proteomic analysis revealed a range of enzymes involved in amino acid metabolism (glutamine synthetase, malate synthase G, arginine deiminase) and ATP synthesis (ATP synthase subunit alpha and beta, ubiquinol-cytochrome c reductase) protein chaperones (chaperone protein DnaK, chaperone SurA, 10 kDa chaperonin, chaperone protein ClpB, trigger factor) and with the uptake of nutrients including iron (ferric iron-binding periplasmic protein HitA) and amino acids [amino acid (lysine/arginine/ornithine/histidine/octopine) ABC transporter periplasmic binding protein, leucine-, isoleucine-, valine-, threonine- and alanine-binding protein]. Proteins involved with the glyoxylate shunt were also detected, including malate synthase G and isocitrate lyase. Several proteins associated with detoxification (catalase, thioredoxin, glutathione peroxidase, xenobiotic reductase and thiol:disulphide interchange protein DsbA) and redox regulation (isocitrate dehydrogenase, citrate synthase and oxoglutarate dehydrogenase) were identified in the dataset (Dataset S1).

The proteomic response of A. fumigatus to P. aeruginosa CuF

Changes to the proteome of A. fumigatus in response to P. aeruginosa CuF were investigated by LFQ proteomics, which was performed on A. fumigatus exposed to P. aeruginosa CuF, and A. fumigatus CuF (control) (n=4). In total, 2414 proteins were identified, of which 1373 remained after filtering and processing (Dataset S2). Of the 1373 proteins identified post-imputation, a comparison between the two groups yielded 272 proteins which were determined to be statistically significant (P<0.05) differentially abundant (SSDA) with a fold change of ±1.5 (Dataset S3). A PCA was performed on all filtered proteins and identified distinct proteomic differences between the groups (Fig. 3a). Components 1 and 2 accounted for 64.5 % of the total variance within the data, and all replicates resolved into their corresponding samples. The groups exposed to A. fumigatus CuF (control) displayed a clear difference from those that were challenged with P. aeruginosa CuF.

Fig. 3.

Fig. 3.

(a) PCA of A. fumigatus protein groups. PCA of A. fumigatus exposed to A. fumigatus CuF (blue) and P. aeruginosa CuF (orange). A clear distinction can be observed between each of the groups exposed to P. aeruginosa CuF and A. fumigatus CuF. (b) Differential abundance of proteins in the A. fumigatus proteome. Volcano plots derived from pairwise comparisons between A. fumigatus cultured in P. aeruginosa CuF and A. fumigatus CuF. The distribution of quantified proteins according to P value (−log10 P-value) and fold change (log2 mean LFQ intensity difference) is shown. Proteins above the line are considered statistically significant (P<0.05). The top 10 statistically significant proteins that increased in abundance are highlighted in red. The top 10 statistically significant proteins that decreased in abundance are highlighted in blue. The gene names are included beside each protein.

Volcano plots were produced by pairwise Student’s t-tests (P<0.05) to determine the differences in protein abundance between two samples and to depict the changes in pathways and processes in which those proteins are involved (Fig. 3b). The top 10 proteins that most increased and decreased in relative abundance are highlighted in the volcano plot and listed in Table 1. SSDA protein names arising from the pairwise t-tests were inputted into Uniprot (uniprot.org) and used to identify the GO terms and metabolic pathways to which proteins belonged.

Table 1.

Relative fold differences of the top 20 SSDA (t-test, P<0.05) proteins detected in the proteomic dataset arising from A. fumigatus groups exposed to A. fumigatus CuF and P. aeruginosa CuF

Gene

Protein name

Fold change

hhtA

AFUA_1G17440 (psoC) ftmOx1

AFUA_5G03540

AFUA_2G15290

NRPS14

AFUA_7G04490

AFUA_6G04920

AFUA_8G00440 (psoF)

Histone H3

Methyltransferase psoC

Verruculogen synthase

Thioredoxin reductase, putative

DUF636 domain protein

Non-ribosomal peptide synthetase 14

Ribosomal protein S28e

Formate dehydrogenase

Dual-functional monooxygenase/methyltransferase psoF

+53.81

+49.55

+44.10

+43.91

+37.79

+24.69

+18.90

+18.64

+18.35

(AFUA_6G09740) gliT

AFUA_1G17440

AFUA_6G09730 (gliF)

AFUA_6G09720 (gliN)

AFUA_2G11120

AFUA_6G09690 (gliG)

AFUA_6G12780

crf2

AFUA_5G09680

AFUA_6G09745

AFUA_5G01880

Thioredoxin reductase gliT

ABC multidrug transporter A-1

Cytochrome P450 monooxygenase gliF

N-Methyltransferase gliN

Uncharacterized protein

Glutathione S-transferase gliG

Uncharacterized protein

Probable glycosidase crf2

Succinate dehydrogenase cytochrome b560 subunit

Uncharacterized protein

Uncharacterized protein

−53.23

−34.45

−28.47

−21.13

−14.49

−12.55

−10.58

−10.34

−8.45

−7.26

−6.75

The data arising from Student’s t-tests (P<0.05) revealed distinct differences in the proteomic response of A. fumigatus when exposed to the P. aeruginosa culture filtrate compared with that of its own (Dataset S3). These differences were most evident in the changes to the proteomic profile of secondary metabolites. The relative abundance of proteins involved in pseurotin A biosynthesis [methyltransferase psoC (+49.55-fold), PKS-NRPS hybrid synthetase psoA (+24.69-fold), methyltransferase psoF (+18.35-fold), glutathione S-transferase psoE (+5.37-fold)], verruculogen [verruculogen synthase (+44.10-fold)] and fumitremorgin biosynthesis [6-hydroxytryprostatin B O-methyltransferase (+11.45-fold)] and brevianamide F [tryprostatin B synthase (+3.69-fold)] were increased significantly (Table 2). In contrast, the relative abundances of several proteins involved in gliotoxin biosynthesis were significantly decreased in A. fumigatus cultures exposed to P. aeruginosa CuF compared to A. fumigatus CuF. These included the protein products of gliF (−28.47-fold), gliG (−12.55-fold), gliN (−21.13-fold) and gliT (−52.23-fold) (Table 2). Other proteins involved in detoxification pathways included GST N-terminal domain-containing protein (−1.81-fold), Peptide-methionine (S)-S-oxide reductase (−4.86-fold) and DNA damage response protein (Dap1) (−3.32-fold).

Table 2.

Changes in the abundance of proteins associated with secondary metabolite biosynthesis: relative fold differences of SSDA (t-test, P<0.05) proteins associated with secondary metabolite biosynthesis between A. fumigatus groups exposed to A. fumigatus CuF and P. aeruginosa CuF

Gene

Protein name

Fold change

AFUA_1G17440 (psoC)

Methyltransferase psoC

+49.55

ftmOx1

Verruculogen synthase

+44.10

NRPS14

PKS-NRPS hybrid synthetase psoA

+24.69

AFUA_8G00440 (psoF)

Methyltransferase psoF

+18.35

ftmMT

6-Hydroxytryprostatin B O-methyltransferase

+11.45

af390-400

O-Methyltransferase af390-400

+7.18

(AFUA_8G00580) psoE

Glutathione S-transferase psoE

+5.37

af380

Polyketide transferase af380

+4.24

ftmPT1

Tryprostatin B synthase

+3.69

AFUA_5G04080

Terpene cyclase

+1.54

(AFUA_6G09740) gliT

Thioredoxin reductase gliT

−53.23

(AFUA_6G09730) gliF

Cytochrome P450 monooxygenase gliF

−28.47

(AFUA_6G09720) gliN

N-Methyltransferase gliN

−21.13

(AFUA_6G09690) gliG

Glutathione S-transferase gliG

−12.55

The proteomic data revealed several differentially abundant proteins typically associated with the cellular response to stress in A. fumigatus cultures exposed to P. aeruginosa CuF. There were clear differences in the type of stress-response proteins, with one group showing an increase in the abundance of proteins involved in a general stress response [e.g. thioredoxin (+43.91-fold), catalase (+3.64-fold), formate dehydrogenase (+18.64-fold)] in A. fumigatus exposed to P. aeruginosa CuF. The other group of stress-related proteins were involved in mitochondrial-induced stress and included decreased levels of cytochrome proteins in the fungal cultures exposed to P. aeruginosa CuF compared to those exposed to A. fumigatus CuF (Table 3).

Table 3.

Changes to the A. fumigatus stress response pathway: relative fold differences of SSDA (t-test, P<0.05) proteins associated with a general stress response and mitochondria-related oxidative stress between A. fumigatus groups exposed to P. aeruginosa CuF and A. fumigatus CuF

Gene

Protein

Fold change

AFUA_5G03540

Thioredoxin reductase

+43.91

AFUA_6G04920

Formate dehydrogenase

+18.64

AFUA_3G14540

Heat shock protein Hsp30/Hsp42

+6.67

AFUA_5G09330

CipC-like antibiotic response protein, putative

+6.08

AFUA_8G06080

Nitric oxide dioxygenase

+3.75

katG

Catalase-peroxidase

+3.64

AFUA_3G12560

Allantoicase Alc

+3.27

AFUA_1G08880

Iron/copper transporter Atx1

+3.22

AFUA_4G03120

Mitochondrial cytochrome b2, putative

+2.93

AFUA_4G11250

Carbonic anhydrase

+2.27

AFUA_7G02070

AIF-like mitochondrial oxidoreductase

+2.25

AFUA_2G05060

Alternative oxidase

+1.95

Pmp20

Putative peroxiredoxin pmp20

+1.89

AFUA_4G03900

Peroxisomal multifunctional beta-oxidation protein

+1.83

Atg8

Autophagy-related protein 8

+1.80

AFUA_1G11180

Heat shock protein/chaperonin HSP78, putative

+1.56

svf1

Survival factor 1

+1.54

AFUA_5G09680

Succinate dehydrogenase cytochrome b560 subunit

−8.45

AFUA_4G11390

Ubiquinol-cytochrome c reductase complex 17 kd protein

−5.85

AFUA_2G13110

Cytochrome c

−1.94

AFUA_4G06790

Cytochrome b-c1 complex subunit 7

−1.83

AFUA_3G06190

Cytochrome c oxidase subunit VIa, putative

−1.54

AFUA_2G11750

Mitochondrial DnaJ chaperone (Mdj1), putative

−1.51

The proteomic dataset revealed significant changes in the abundance of proteins involved with transcriptional and translational regulation. These included ribosomal proteins belonging to the large and small ribosome (ribosomal protein S28e; +18.9fold), 60S ribosomal protein L36; +15.59-fold), proteins involved in splicing (U6 snRNA-associated Sm-like protein LSm6; +2.84-fold, pre-mRNA-splicing factor rse1; +2.07-fold), histone proteins (histone H3; +53.81-fold, histone H2B; +2.29-fold), and regulatory proteins such as translation initiation (eukaryotic translation initiation factor 4C; +4.63-fold) and elongation factors (eukaryotic translation elongation factor 1 subunit Eef1-beta; +1.70-fold). While the greatest changes were detected in the groups that had increased in relative abundance, there were a large proportion of proteins belonging to this group that had also decreased in relative abundance in A. fumigatus exposed to P. aeruginosa CuF (40S ribosomal protein S2; −4.31-fold, 60S acidic ribosomal protein P2; −4.15-fold, 50S ribosomal protein L13; −3.16-fold, eukaryotic translation initiation factor 3 subunit K; −3.31-fold) (Table S1, Dataset S3).

Discussion

The inhibitory effects of P. aeruginosa cells and P. aeruginosa secondary metabolites on A. fumigatus biofilm formation and fungal growth and development are well established [27, 28, 37, 43, 44]. However, the proteomic response of A. fumigatus to the P. aeruginosa secreteome remains largely uncharacterized. The results presented in this study demonstrate distinct differences in fungal growth and gliotoxin production where A. fumigatus is exposed to P. aeruginosa cells, compared to its exposure to P. aeruginosa CuF. We chose to use a nutrient-poor, nitrate-rich liquid medium, Czapek-Dox, in which to culture A. fumigatus and to produce the P. aeruginosa culture filtrates. Czapek-Dox is used to promote the production of redox-active secondary metabolites such as gliotoxin [34, 45, 46] and provides a nitrate-rich environment, which is a feature of CF airways [34, 45–47].

Exposure of A. fumigatus to P. aeruginosa cells resulted in reduced fungal growth and an increase in gliotoxin production. The growth-inhibiting effect of P. aeruginosa on A. fumigatus has been reported previously [28, 29, 39, 48, 49]. Rhamnolipids are a family of glycolipids produced by P. aeruginosa and other Pseudomonas species [50]. Dirhamnolipids produced by P. aeruginosa inhibit β 1, 3-glucan synthase, thereby interfering with fungal cell-wall architecture [43]. Other mediators of fungal growth inhibition include pyoverdin, a bacterial siderophore that sequesters iron from the environment, and pyocyanin which disrupts the redox balance in the environment [28, 29]. Exposure of A. fumigatus to siderophore-deficient P. aeruginosa strains does not negatively impact fungal growth [48]. We used a siderophore-sufficient strain of P. aeruginosa , PAO1, which may in part explain the ability of these bacteria to inhibit fungal growth under the conditions we applied in this experiment. Analysis of the dataset arising from MS analysis of the bacterial secretome detected one protein associated with iron acquisition, ferric iron-binding periplasmic protein HitA.

Since gliotoxin is responsible for maintaining redox homeostasis in the fungus, an increase in gliotoxin production may be indicative of bacterial-mediated induction of reactive oxygen species, which is known to compromise fungal growth and survival [28]. Gliotoxin displays immunosuppressive effects on host cells [51–53] and thus, in the context of co-infection, the propensity of P. aeruginosa to promote gliotoxin production in A. fumigatus may have serious implications for host health.

To characterize the effect of the P. aeruginosa secretome on A. fumigatus growth and gliotoxin production, A. fumigatus cultures were exposed to P. aeruginosa CuF or A. fumigatus CuF for 24 h. The growth of fungal cultures when incubated with A. fumigatus CuF or P. aeruginosa CuF increased 1.36- and 2.8-fold respectively, relative to the control. Conversely, gliotoxin production was lower in fungal cultures exposed to P. aeruginosa CuF.

These results indicate that the response of A. fumigatus to P. aeruginosa may be regulated through direct (via bacterial cells) and indirect (via bacterial secretome) interactions with the bacteria, and that such interactions can determine hyphal formation and the secretory profile of the fungus, which may in turn have clinical significance for the host, depending on the proximity of the two pathogens to each other. Competition for nutrients such as iron, which occur when two organisms share an environment with limited resources, lead to growth inhibition of the weaker species, which, in the context of P. aeruginosa and A. fumigatus, is often the latter [28, 32, 48].

The results observed in this study contradict those observed in previous studies, in which the culture filtrates produced by P. aeruginosa PAO1 inhibited fungal growth [48]. However, given that the growth media used in the two studies differ in composition, this probably has implications for the biochemical profile of the secretome, and hence the effect on the fungal response in terms of growth. The positive effect of P. aeruginosa -mediated fungal growth has been described previously [35, 36] and the promotion of fungal growth was attributed to volatile sulphur compounds (VSCs), produced by P. aeruginosa on a spatially separate part of sulphur-deficient agar plates. However, bacterial VOCs can also be growth inhibitors [37]. Because VOCs can be emitted into liquid media [54], it is possible that these compounds may have had some effect on the growth of A. fumigatus under the culture conditions described here, but our experimental design did not allow for analysis of VOCs.

To characterize the protein profile of the P. aeruginosa CuF, we analysed the secretome by LFQ proteomics using high-resolution MS. Czapek-Dox liquid media can support the growth of P. aeruginosa , although poorly compared to other growth media due to its low nutritional content [34]. We have shown previously that the growth of P. aeruginosa in this medium can be promoted when conditioned in the culture filtrates produced by A. fumigatus in Czapek-Dox. We used MS-based proteomics to analyse the secretome of the A. fumigatus CuF and concluded that A. fumigatus creates a nutrient-rich environment which supplies P. aeruginosa with the nutritional components it requires to proliferate in an otherwise hostile environment [34]. Here, we used the same proteomics technique to investigate the profile of the P. aeruginosa secretome produced in Czapek-Dox, with a view to understanding how the bacterial culture filtrates alter the A. fumigatus growth and proteomic profile. We discovered a number of proteins in the dataset which provide insight as to how P. aeruginosa conditions this growth medium which alters fungal growth.

The glyoxylate shunt (GS) is a metabolic process whereby bacteria metabolize acetate and fatty acids as carbon sources, and which may be used as an alternative to the TCA cycle [55, 56]. This two-step pathway involves isocitrate lyase and malate synthase, and is upregulated under conditions of oxidative stress [55, 56]. Both enzymes involved in this pathway were detected in the P. aeruginosa CuF. The CF airways contain higher levels of fatty acids than normal airways [57] and there are indications that in the CF airways fatty acids are the main source of carbon used by P. aeruginosa [58].

A range of proteins involved in detoxification including catalase and thioredoxin, key components of the antioxidant system, were also detected in the culture filtrates, indicating an environmental stress response was adopted by the bacterial cells in this growth medium. Oxidative stress may be caused, in part, by low environmental pH. Bacteria can regulate the pH of their external environment to facilitate their survival [59, 60]. One way in which this may be accomplished is through the production of ammonia ions which, when combined with protons, form ammonium ions, thereby raising the pH of the environment. To achieve this, bacteria may utilize the arginine deiminase pathway, which involves the conversion of arginine to ornithine, ammonia and carbon dioxide [59, 61]. Among the enzymes involved in this process are arginine deiminase and ornithine carbamoyltransferase, both of which were detected in the dataset arising from P. aeruginosa CuF MS analysis. The presence of proteins involved in oxidative stress and pH regulation indicate that the bacteria modified the environment to become more conducive to growth and in doing so increased the pH of the growth media from 6.8 (pre-inoculation) to 7.2 (48 h post-inoculation). It is the higher pH and the abundance of detoxifying enzymes present in the P. aeruginosa CuF that may have created an environment more conducive to the growth of A. fumigatus, and hence greater fungal growth, compared to that created by the A. fumigatus CuF which had a much lower pH (4.5) and which ultimately resulted in lower fungal growth, and a significantly different proteomic profile.

To gain a better insight into the biological pathways and processes that contribute to the response of A. fumigatus to the P. aeruginosa CuF, a whole-cell proteomic approach was adopted. Modifications to histones have been extensively studied and have major implications in fungal growth and development [62, 63]. Proteomic data analysis in this study identified histone 3 as the most differentially abundant protein associated with transcriptional regulation in A. fumigatus cultures exposed to P. aeruginosa CuF (+53.81-fold). Another core component of the nucleosome, histone H2B, was detected in the group exposed to P. aeruginosa CuF and was increased by 2.29-fold compared to groups exposed to A. fumigatus CuF. In contrast, histone H2A.Z was reduced by −2.54-fold. Also reflective of changes to transcriptional and translational activity between groups was the increase in levels of proteins involved with the generation of mRNA transcripts and ribosomal activity, including ribosomal protein S28e (+18.90-fold), ribonucloprotein (+17.04-fold), 60S ribosomal protein L36 (+15.59-fold), eukaryotic translation initiation factor 4C (+4.51-fold) and RNA polymerase II subunit 3 (+2.39-fold). A decrease in the relative abundance of several ribosomal-associated proteins was also evident in the groups exposed to P. aeruginosa CuF. These included 40S ribosomal protein S2 (−4.31-fold) and eukaryotic translation initiation factor 3 subunit K (−3.31-fold). The increases and decreases in the relative abundance of this category of proteins highlight the changes to protein synthesis apparatus and transcriptional/translational processes that are driven by exposure to the bacterial CuF.

One of the most remarkable findings in the proteomic dataset was a significant decrease in the relative abundance of four proteins associated with the gliotoxin biosynthetic gene-cluster in A. fumigatus that had been exposed to P. aeruginosa CuF compared to A. fumigatus CuF. These proteins, thioredoxin reductase gliT (−53.23-fold), cytochrome P450 monooxygenase gliF (−28.47-fold), N-methyltransferase gliN (−21.13-fold) and glutathione S-transferase gliG (−12.55-fold), the gene products of gliT, gliF, gliN and gliG, respectively, were dramatically decreased in A. fumigatus exposed to the P. aeruginosa CuF. These findings correlate with those detected by RP-HPLC whereby gliotoxin production was decreased in fungal cultures grown in the presence of P. aeruginosa CuFs.

In contrast, analysis of the fungal proteome where A. fumigatus was exposed to P. aeruginosa CuF revealed a significant increase in the relative abundance of proteins associated with the biosynthesis of other secondary metabolites including pseurotin A (methyltransferase psoC, +49.55-fold; PKS-NRPS hybrid synthetase psoA, +24.69-fold; methyltransferase psoF; +18.35-fold, glutathione S-transferase psoE, +5.37-fold), verruculogen (verruculogen synthase, +44.10-fold), fumagillin (O-methyltransferase af390−400, +7.18-fold), and fumitremorgins (6-hydroxytryprostatin B O-methyltransferase, +11.45-fold; tryprostatin B synthase, +3.69-fold).

Pseurotin A is a competitive inhibitor of chitin synthase and has been reported to have cytotoxic activity, thereby highlighting its potentially cytotoxic effect on host cells [64–66]. Verruculogen and fumitremorgin b are known to affect the central nervous system in vivo and in vitro; verruculogen alters the electrophysiological properties of human nasal epithelial cells, suggesting this metabolite may participate in fungal colonization of the airways [67, 68]. Fumagillin affects the ability of neutrophils to produce superoxide anions by inhibiting the function of NADPH oxidase and prevents degranulation by interfering with the structural rearrangements required for these processes to occur [69]. An increase in the relative abundance of proteins associated with the biosynthesis of these metabolites in A. fumigatus coupled with a decrease in the relative abundance of gliotoxin biosynthetic proteins indicate that P. aeruginosa creates an environment that causes A. fumigatus to alter secondary metabolite production to adapt to the conditions created by the bacteria.

Contrasting results were observed in a previous study, whereby attenuation of gliotoxin biosynthesis by deletion of the gliotoxin bis-thiomethyltransferase gene, GtmA, corresponded to a decrease in the levels of pseurotinA, fumagillin, tryprostatin B and fumitremorgin C [70]. The findings of both studies highlight the complexities involved in the regulation of secondary metabolite biosynthesis, and demonstrate that their induction at a molecular level may be controlled by multiple environmental stimuli.

An increase in the relative abundance of proteins associated with an oxidative stress response and detoxification (formate dehydrogenase, +18.64-fold; thioredoxin reductase, +43.91-fold; AhpC/TSA family protein, +6.51-fold; catalase-peroxidase, +3.64-fold) was detected in the A. fumigatus proteome where the fungus was exposed to the P. aeruginosa CuF [71–73]. This suggests that the contents of P. aeruginosa CuF induce oxidative stress in A. fumigatus.

The proteomic data also revealed a decrease in the relative abundance of several proteins associated with the mitochondria in A. fumigatus exposed to P. aeruginosa CuF compared with that exposed to A. fumigatus CuF. Alterations to the mitochondria are indicative of an increase in energy production and oxidative stress. The proteins detected here were involved with complex III of the respiratory transport-chain and included succinate dehydrogenase cytochrome b560 subunit (−8.45-fold), ubiquinol-cytochrome c reductase complex 17 kd protein (−5.85-fold), cytochrome C (−1.94-fold) and cytochrome b-c1 complex subunit 7 (−1.83-fold). Oxidative stress induces the release of cytochrome c from the mitochondria and is a signature of mitochondrial dysfunction [74]. The increased levels of proteins associated with cytochrome complexes in the group exposed to A. fumigatus CuF correlate with the increased levels of proteins associated with gliotoxin biosynthesis in these fungal cultures. Gliotoxin is a driver of oxidative stress in the microenvironment and a known contributor to mitochondrial stress, which may explain why indicators of mitochondrial dysfunction are observed in the group exposed to A. fumigatus CuF to a greater extent than those exposed to P. aeruginosa CuF [75–78]. These data indicate that the stress response induced by P. aeruginosa CuF differs to that which is induced by A. fumigatus CuF and, given that certain virulence factors are often dependent upon the type of stress response endured by the pathogen [79], suggests potential implications during instances of co-infection.

A. fumigatus secretes a range of degradative enzymes that contribute to the ubiquity of the fungus in nature by supporting fungal growth on plant matter [4, 5]. Many of these biological determinants also play a role in establishing disease in humans and are associated with virulence and pathogenesis. Several proteases involved in conidial development, and also thought to play a role in ABPA were detected in the data set presented here, including alkaline protease 2 (+2.42-fold), major allergen Asp f 2 (+2.26-fold) and vacuolar protease A (+2.09-fold) [80, 81]. The increase in relative abundance of these enzymes, due to exposure by P. aeruginosa CuF, suggests that the presence of bacterial-derived molecules in the environment potentially promote the expression of the genes encoding such proteins.

Conclusion

In the CF airways, A. fumigatus rarely becomes invasive as germinating conidia are rapidly targeted by cells of the immune system [82, 83]. However, if hyphae are produced, antigens, proteases and other factors that induce an inflammatory response can be released [83]. Because P. aeruginosa is prevalent in the CF airways, it is important to understand the role of bacteria in influencing fungal growth and development. The data presented here indicate that the secreted products of P. aeruginosa can influence the proteomic response of A. fumigatus and, consequently, the effect of the fungus on the host, by way of modulating secondary metabolite production. The role of A. fumigatus proteases in exacerbating pulmonary disorders such as ABPA have been established, but with the exception of gliotoxin, less is known about the effects of other secondary metabolites (e.g. pseurotin A) on the immune system. Given the prevalence of A. fumigatus as an infectious agent and its propensity to co-infect the airways with other pathogens, it may be of interest to investigate whether other bacteria induce similar responses in terms of mycotoxin production.

Supplementary Data

Supplementary material 1
Supplementary material 2

Funding information

Anatte Margalit is the recipient of an Irish Research Council Doctoral scholarship. David Sheehan was funded by a Wellcome Trust Biomedical Vacation 26 Scholarship (Scholarship number: WELLCOME 213358/Z/18Z_SHEEHAN). The Q-exactive mass spectrometer was funded under the SFI Research Infrastructure Call 2012; Grant Number: 12/RI/2346 (3).

Conflicts of interest

The authors declare that there are no conflicts of interest.

Footnotes

Abbreviations: ABPA, allergic bronchopulmonary aspergillosis; CF, cystic fibrosis; CuF, culture filtrate; GS, glyoxylate shunt; LFQ, label-free quantitative; PCA, principal components analysis; RP-HPLC, reversed-phase HPLC; SSDA, statistically significant differentially abundant; TC, tricarboxylic cycle; VOC, volatile organic compound.

Four supplementary tables and one supplementary figure are available with the online version of this article.

References

  • 1.Vivek-Ananth RP, Mohanraj K, Vandanashree M, Jhingran A, Craig JP, et al. Comparative systems analysis of the secretome of the opportunistic pathogen Aspergillus fumigatus and other Aspergillus species. Sci Rep. 2018;8:6617. doi: 10.1038/s41598-018-25016-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Wartenberg D, Lapp K, Jacobsen ID, Dahse H-M, Kniemeyer O, et al. Secretome analysis of Aspergillus fumigatus reveals Asp-hemolysin as a major secreted protein. Int J Med Microbiol. 2011;301:602–611. doi: 10.1016/j.ijmm.2011.04.016. [DOI] [PubMed] [Google Scholar]
  • 3.Behnsen J, Lessing F, Schindler S, Wartenberg D, Jacobsen ID, et al. Secreted Aspergillus fumigatus protease Alp1 degrades human complement proteins C3, C4, and C5. Infect Immun. 2010;78:3585–3594. doi: 10.1128/IAI.01353-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Wang D, Zhang L, Zou H, Wang L. Secretome profiling reveals temperature-dependent growth of Aspergillus fumigatus . Sci China Life Sci. 2018;61:578–592. doi: 10.1007/s11427-017-9168-4. [DOI] [PubMed] [Google Scholar]
  • 5.Tekaia F, Latgé J-P. Aspergillus fumigatus: saprophyte or pathogen? Curr Opin Microbiol. 2005;8:385–392. doi: 10.1016/j.mib.2005.06.017. [DOI] [PubMed] [Google Scholar]
  • 6.Paulussen C, Hallsworth JE, Álvarez-Pérez S, Nierman WC, Hamill PG, et al. Ecology of aspergillosis: insights into the pathogenic potency of Aspergillus fumigatus and some other Aspergillus species. Microb Biotechnol. 2017;10:296–322. doi: 10.1111/1751-7915.12367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Bignell E, Cairns TC, Throckmorton K, Nierman WC, Keller NP. Secondary metabolite arsenal of an opportunistic pathogenic fungus. Phil Trans R Soc B. 2016;371:20160023. doi: 10.1098/rstb.2016.0023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Inglis DO, Binkley J, Skrzypek MS, Arnaud MB, Cerqueira GC, et al. Comprehensive annotation of secondary metabolite biosynthetic genes and gene clusters of Aspergillus nidulans, A. fumigatus, A. niger and A. oryzae . BMC Microbiol. 2013;13:91. doi: 10.1186/1471-2180-13-91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Raffa N, Keller NP, Sheppard DC. A call to arms: Mustering secondary metabolites for success and survival of an opportunistic pathogen. PLOS Pathog. 2019;15:e1007606. doi: 10.1371/journal.ppat.1007606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Amin S, Thywissen A, Heinekamp T, Saluz HP, Brakhage AA. Melanin dependent survival of Apergillus fumigatus conidia in lung epithelial cells. Int J Med Microbiol. 2014;304:626–636. doi: 10.1016/j.ijmm.2014.04.009. [DOI] [PubMed] [Google Scholar]
  • 11.Fallon JP, Reeves EP, Kavanagh K. Inhibition of neutrophil function following exposure to the Aspergillus fumigatus toxin fumagillin. J Med Microbiol. 2010;59:625–633. doi: 10.1099/jmm.0.018192-0. [DOI] [PubMed] [Google Scholar]
  • 12.Schlam D, Canton J, Carreño M, Kopinski H, Freeman SA, et al. Gliotoxin suppresses macrophage immune function by subverting phosphatidylinositol 3,4,5-trisphosphate homeostasis. mBio. 2016;7:1–15. doi: 10.1128/mBio.02242-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Coburn B, Wang PW, Diaz Caballero J, Clark ST, Brahma V, et al. Lung microbiota across age and disease stage in cystic fibrosis. Sci Rep. 2015;5:10241. doi: 10.1038/srep10241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Breuer O, Schultz A, Garratt LW, Turkovic L, Rosenow T, et al. Aspergillus infections and progression of structural lung disease in children with cystic fibrosis. Am J Respir Crit Care Med. 2020;201:688–696. doi: 10.1164/rccm.201908-1585OC. [DOI] [PubMed] [Google Scholar]
  • 15.Reece E, McClean S, Greally P, Renwick J. The prevalence of Aspergillus fumigatus in early cystic fibrosis disease is underestimated by culture-based diagnostic methods. J Microbiol Methods. 2019;164:105683. doi: 10.1016/j.mimet.2019.105683. [DOI] [PubMed] [Google Scholar]
  • 16.Stevens DA, Moss RB, Kurup VP, Knutsen AP, Greenberger P, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis. 2003;37 Suppl 3:S225–64. doi: 10.1086/376525. [DOI] [PubMed] [Google Scholar]
  • 17.Maturu VN, Agarwal R. Prevalence of Aspergillus sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis: systematic review and meta-analysis. Clin Exp Allergy. 2015;45:1765–1778. doi: 10.1111/cea.12595. [DOI] [PubMed] [Google Scholar]
  • 18.Denning DW, Pleuvry A, Cole DC. Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. Med Mycol. 2013;51:361–370. doi: 10.3109/13693786.2012.738312. [DOI] [PubMed] [Google Scholar]
  • 19.Armstead J, Morris J, Denning DW. Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis. PLOS ONE. 2014;9:e98502. doi: 10.1371/journal.pone.0098502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Reece E, Segurado R, Jackson A, McClean S, Renwick J, et al. Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis. BMC Pulm Med. 2017;17:1–8. doi: 10.1186/s12890-017-0416-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Zhao J, Cheng W, He X, Liu Y. The co-colonization prevalence of Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis: A systematic review and meta-analysis. Microb Pathog. 2018;125:122–128. doi: 10.1016/j.micpath.2018.09.010. [DOI] [PubMed] [Google Scholar]
  • 22.Fothergill JL, Walshaw MJ, Winstanley C. Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections. Eur Respir J. 2012;40:227–238. doi: 10.1183/09031936.00204411. [DOI] [PubMed] [Google Scholar]
  • 23.Hector A, Kirn T, Ralhan A, Graepler-Mainka U, Berenbrinker S, et al. Microbial colonization and lung function in adolescents with cystic fibrosis. J Cyst Fibros. 2016;15:340–349. doi: 10.1016/j.jcf.2016.01.004. [DOI] [PubMed] [Google Scholar]
  • 24.Reece E, Segurado R, Jackson A, McClean S, Renwick J, et al. Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis. BMC Pulm Med. 2017;17:70. doi: 10.1186/s12890-017-0416-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Zhao J, Cheng W, He X, Liu Y. The co-colonization prevalence of Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis: A systematic review and meta-analysis. Microb Pathog. 2018;125:122–128. doi: 10.1016/j.micpath.2018.09.010. [DOI] [PubMed] [Google Scholar]
  • 26.Paugam A, Baixench M-T, Demazes-Dufeu N, Burgel P-R, Sauter E, et al. Characteristics and consequences of airway colonization by filamentous fungi in 201 adult patients with cystic fibrosis in France. Med Mycol. 2010;48 Suppl 1:S32–6. doi: 10.3109/13693786.2010.503665. [DOI] [PubMed] [Google Scholar]
  • 27.Yonezawa M, Sugiyama H, Kizawa K, Hori R, Mitsuyama J, et al. A new model of pulmonary superinfection with Aspergillus fumigatus and Pseudomonas aeruginosa in mice. J Infect Chemother. 2000;6:155–161. doi: 10.1007/s101560070015. [DOI] [PubMed] [Google Scholar]
  • 28.Briard B, Bomme P, Lechner BE, Mislin GLA, Lair V, et al. Pseudomonas aeruginosa manipulates redox and iron homeostasis of its microbiota partner Aspergillus fumigatus via phenazines. Sci Rep. 2015;5:8220. doi: 10.1038/srep08220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Sass G, Nazik H, Penner J, Shah H, Ansari SR, et al. Studies of Pseudomonas aeruginosa mutants indicate pyoverdine as the central factor in inhibition of Aspergillus fumigatus biofilm. J Bacteriol. 2018;200:1–24. doi: 10.1128/JB.00345-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Shirazi F, Ferreira JAG, Stevens DA, Clemons KV, Kontoyiannis DP. Biofilm filtrates of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients inhibit preformed Aspergillus fumigatus biofilms via apoptosis. PLoS One. 2016;11:e0150155. doi: 10.1371/journal.pone.0150155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Ferreira JAG, Penner JC, Moss RB, Haagensen JAJ, Clemons KV, et al. Inhibition of Aspergillus fumigatus and its biofilm by Pseudomonas aeruginosa is dependent on the source, phenotype and growth conditions of the bacterium. PLOS ONE. 2015;10:e0134692. doi: 10.1371/journal.pone.0134692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Mowat E, Rajendran R, Williams C, McCulloch E, Jones B, et al. Pseudomonas aeruginosa and their small diffusible extracellular molecules inhibit Aspergillus fumigatus biofilm formation. FEMS Microbiology Letters. 2010;313:96–102. doi: 10.1111/j.1574-6968.2010.02130.x. [DOI] [PubMed] [Google Scholar]
  • 33.Reece E, Doyle S, Greally P, Renwick J, McClean S. Aspergillus fumigatus inhibits Pseudomonas aeruginosa in co-culture: implications of a mutually antagonistic relationship on virulence and inflammation in the CF airway. Front Microbiol. 2018;9:1–14. doi: 10.3389/fmicb.2018.01205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Margalit A, Carolan JC, Sheehan D, Kavanagh K. The Aspergillus fumigatus secretome alters the proteome of Pseudomonas aeruginosa to stimulate bacterial growth: implications for co-infection. Molecular & Cellular Proteomics. 2020;19:1346–1359. doi: 10.1074/mcp.RA120.002059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Briard B, Heddergott C, Latgé J-P, Taylor JW, Dunlap JC, et al. Volatile compounds emitted by Pseudomonas aeruginosa stimulate growth of the fungal pathogen Aspergillus fumigatus . mBio. 2016;7:1–5. doi: 10.1128/mBio.00219-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Scott J, Sueiro-Olivares M, Ahmed W, Heddergott C, Zhao C, et al. Pseudomonas aeruginosa-derived volatile sulfur compounds promote distal Aspergillus fumigatus growth and a synergistic pathogen-pathogen interaction that increases pathogenicity in co-infection. Front Microbiol. 2019;10:2311. doi: 10.3389/fmicb.2019.02311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Nazik H, Sass G, Déziel E, Stevens DA. Aspergillus is inhibited by Pseudomonas aeruginosa volatiles. JoF. 2020;6:118. doi: 10.3390/jof6030118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Smith K, Rajendran R, Kerr S, Lappin DF, Mackay WG, et al. Aspergillus fumigatus enhances elastase production in Pseudomonas aeruginosa co-cultures. Med Mycol. 2015;53:645–655. doi: 10.1093/mmy/myv048. [DOI] [PubMed] [Google Scholar]
  • 39.Sass G, Ansari SR, Dietl A-M, Déziel E, Haas H, et al. Intermicrobial interaction: Aspergillus fumigatus siderophores protect against competition by Pseudomonas aeruginosa . PLoS One. 2019;14:e0216085. doi: 10.1371/journal.pone.0216085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Hubner NC, Bird AW, Cox J, Splettstoesser B, Bandilla P, et al. Quantitative proteomics combined with BAC TransgeneOmics reveals in vivo protein interactions. J Cell Biol. 2010;189:739–754. doi: 10.1083/jcb.200911091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Côté RG, Griss J, Dianes JA, Wang R, Wright JC, et al. The PRoteomics IDEntification (PRIDE) converter 2 framework: an improved suite of tools to facilitate data submission to the PRIDE Database and the ProteomeXchange Consortium. Molecular & Cellular Proteomics. 2012;11:1682–1689. doi: 10.1074/mcp.O112.021543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Murphy S, Zweyer M, Mundegar RR, Swandulla D, Ohlendieck K. Proteomic identification of elevated saliva kallikrein levels in the mdx-4cv mouse model of Duchenne muscular dystrophy. Biochem Biophys Rep. 2019;18:100541. doi: 10.1016/j.bbrep.2018.05.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Briard B, Rasoldier V, Bomme P, ElAouad N, Guerreiro C, et al. Dirhamnolipids secreted from Pseudomonas aeruginosa modify anjpegungal susceptibility of Aspergillus fumigatus by inhibiting β1,3 glucan synthase activity. ISME J. 2017;11:1578–1591. doi: 10.1038/ismej.2017.32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Briard B, Mislin GLA, Latgé J-P, Beauvais A. Interactions between Aspergillus fumigatus and pulmonary bacteria: current state of the field, new data, and future perspective. J Fungi (Basel) 2019;5:48. doi: 10.3390/jof5020048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Cramer RA, Gamcsik MP, Brooking RM, Najvar LK, Kirkpatrick WR, et al. Disruption of a nonribosomal peptide synthetase in Aspergillus fumigatus eliminates gliotoxin production. Eukaryot Cell. 2006;5:972–980. doi: 10.1128/EC.00049-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Dolan SK, Owens RA, O’Keeffe G, Hammel S, Fitzpatrick DA, et al. Regulation of nonribosomal peptide synthesis: bis-thiomethylation attenuates gliotoxin biosynthesis in Aspergillus fumigatus . Chem Biol. 2014;21:999–1012. doi: 10.1016/j.chembiol.2014.07.006. [DOI] [PubMed] [Google Scholar]
  • 47.Line L, Alhede M, Kolpen M, Kühl M, Ciofu O, et al. Physiological levels of nitrate support anoxic growth by denitrification of Pseudomonas aeruginosa at growth rates reported in cystic fibrosis lungs and sputum. Front Microbiol. 2014;5:554. doi: 10.3389/fmicb.2014.00554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Wurster S, Sass G, Albert ND, Nazik H, Déziel E, et al. Live imaging and quantitative analysis of Aspergillus fumigatus growth and morphology during inter-microbial interaction with Pseudomonas aeruginosa . Virulence. 2020;11:1329–1336. doi: 10.1080/21505594.2020.1827885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Margalit A, Carolan JC, Kavanagh K. Bacterial Interactions with Aspergillus fumigatus in the Immunocompromised Lung. Microorganisms. 2021;9:435. doi: 10.3390/microorganisms9020435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Abalos A, Pinazo A, Infante MR, Casals M, García F, et al. Physicochemical and antimicrobial properties of new rhamnolipids produced by Pseudomonas a eruginosa AT10 from soybean oil refinery wastes. Langmuir. 2001;17:1367–1371. doi: 10.1021/la0011735. [DOI] [Google Scholar]
  • 51.Stanzani M, Orciuolo E, Lewis R, Kontoyiannis DP, Martins SLR, et al. Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes. Blood. 2005;105:2258–2265. doi: 10.1182/blood-2004-09-3421. [DOI] [PubMed] [Google Scholar]
  • 52.Schlam D, Canton J, Carreño M, Kopinski H, Freeman SA, et al. Gliotoxin suppresses macrophage immune function by subverting phosphatidylinositol 3,4,5-trisphosphate homeostasis. mBio. 2016;7:e02242. doi: 10.1128/mBio.02242-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Orciuolo E, Stanzani M, Canestraro M, Galimberti S, Carulli G, et al. Effects of Aspergillus fumigatus gliotoxin and methylprednisolone on human neutrophils: implications for the pathogenesis of invasive aspergillosis. J Leukoc Biol. 2007;82:839–848. doi: 10.1189/jlb.0207090. [DOI] [PubMed] [Google Scholar]
  • 54.Reese KL, Rasley A, Avila JR, Jones AD, Frank M. Metabolic Profiling of Volatile Organic Compounds (VOCs) emitted by the pathogens Francisella tularensis and Bacillus anthracis in liquid culture. Sci Rep. 2020;10:9333. doi: 10.1038/s41598-020-66136-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.da Cruz Nizer WS, Inkovskiy V, Versey Z, Strempel N, Cassol E, et al. Oxidative stress response in Pseudomonas aeruginosa . Pathogens. 2021;10:1187. doi: 10.3390/pathogens10091187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Ahn S, Jung J, Jang I-A, Madsen EL, Park W. Role of glyoxylate shunt in oxidative stress response. J Biol Chem. 2016;291:11928–11938. doi: 10.1074/jbc.M115.708149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Meyer KC, Sharma A, Brown R, Weatherly M, Moya FR, et al. Function and composition of pulmonary surfactant and surfactant-derived fatty acid profiles are altered in young adults with cystic fibrosis. Chest. 2000;118:164–174. doi: 10.1378/chest.118.1.164. [DOI] [PubMed] [Google Scholar]
  • 58.Son MS, Matthews WJ Jr, Kang Y, Nguyen DT, Hoang TT. In vivo evidence of Pseudomonas aeruginosa nutrient acquisition and pathogenesis in the lungs of cystic fibrosis patients. Infect Immun. 2007;75:5313–5324. doi: 10.1128/IAI.01807-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Lund P, Tramonti A, De Biase D. Coping with low pH: molecular strategies in neutralophilic bacteria. FEMS Microbiol Rev. 2014;38:1091–1125. doi: 10.1111/1574-6976.12076. [DOI] [PubMed] [Google Scholar]
  • 60.Ratzke C, Gore J. Modifying and reacting to the environmental pH can drive bacterial interactions. PLoS Biol. 2018;16:e2004248. doi: 10.1371/journal.pbio.2004248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Cunin R, Glansdorff N, Piérard A, Stalon V. Biosynthesis and metabolism of arginine in bacteria. Microbiol Rev. 1986;50:314–352. doi: 10.1128/mr.50.3.314-352.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Brosch G, Loidl P, Graessle S. Histone modifications and chromatin dynamics: a focus on filamentous fungi. FEMS Microbiol Rev. 2008;32:409–439. doi: 10.1111/j.1574-6976.2007.00100.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Palmer JM, Perrin RM, Dagenais TRT, Keller NP. H3K9 methylation regulates growth and development in Aspergillus fumigatus . Eukaryot Cell. 2008;7:2052–2060. doi: 10.1128/EC.00224-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Bladt TT, Frisvad JC, Knudsen PB, Larsen TO. Anticancer and antifungal compounds from Aspergillus, Penicillium and other filamentous fungi. Molecules. 2013;18:11338–11376. doi: 10.3390/molecules180911338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Martínez-Luis S, Cherigo L, Arnold E, Spadafora C, Gerwick WH, et al. Antiparasitic and anticancer constituents of the endophytic fungus Aspergillus sp. strain F1544. Nat Prod Commun. 2012;7:1934578X1200700. doi: 10.1177/1934578X1200700207. [DOI] [PubMed] [Google Scholar]
  • 66.Wenke J, Anke H, Sterner O. Pseurotin A and 8- O -Demethylpseurotin A from Aspergillus fumigatus and their inhibitory activities on chitin synthase. Biosci Biotechnol Biochem. 2014;57:961–964. doi: 10.1271/bbb.57.961. [DOI] [Google Scholar]
  • 67.Khoufache K, Puel O, Loiseau N, Delaforge M, Rivollet D, et al. Verruculogen associated with Aspergillus fumigatus hyphae and conidia modifies the electrophysiological properties of human nasal epithelial cells. BMC Microbiol. 2007;7:5. doi: 10.1186/1471-2180-7-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Tepšič K, Gunde-Cimerman N, Frisvad JC. Growth and mycotoxin production by Aspergillus fumigatus strains isolated from a saltern. FEMS Microbiology Letters. 2006;157:9–12. doi: 10.1111/j.1574-6968.1997.tb12745.x. [DOI] [Google Scholar]
  • 69.Fallon JP, Reeves EP, Kavanagh K. Inhibition of neutrophil function following exposure to the Aspergillus fumigatus toxin fumagillin. J Med Microbiol. 2010;59:625–633. doi: 10.1099/jmm.0.018192-0. [DOI] [PubMed] [Google Scholar]
  • 70.Doyle S, Jones GW, Dolan SK. Dysregulated gliotoxin biosynthesis attenuates the production of unrelated biosynthetic gene cluster-encoded metabolites in Aspergillus fumigatus . Fungal Biol. 2018;122:214–221. doi: 10.1016/j.funbio.2017.12.007. [DOI] [PubMed] [Google Scholar]
  • 71.Sugui JA, Kim HS, Zarember KA, Chang YC, Gallin JI, et al. Genes differentially expressed in conidia and hyphae of Aspergillus fumigatus upon exposure to human neutrophils. PLOS ONE. 2008;3:e2655. doi: 10.1371/journal.pone.0002655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Marshall AC, Kidd SE, Lamont-Friedrich SJ, Arentz G, Hoffmann P, et al. Structure, mechanism, and inhibition of Aspergillus fumigatus thioredoxin reductase. Antimicrob Agents Chemother. 2019;63:e02281-18. doi: 10.1128/AAC.02281-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Paris S, Wysong D, Debeaupuis J-P, Shibuya K, Philippe B, et al. Catalases of Aspergillus fumigatus . Infect Immun. 2003;71:3551–3562. doi: 10.1128/IAI.71.6.3551-3562.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Li L, Hu X, Xia Y, Xiao G, Zheng P, et al. Linkage of oxidative stress and mitochondrial dysfunctions to spontaneous culture degeneration in Aspergillus nidulans . Mol Cell Proteomics. 2014;13:449–461. doi: 10.1074/mcp.M113.028480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Gayathri L, Akbarsha MA, Ruckmani K. In vitro study on aspects of molecular mechanisms underlying invasive aspergillosis caused by gliotoxin and fumagillin, alone and in combination. Sci Rep. 2020;10:14473. doi: 10.1038/s41598-020-71367-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Islam MT, Mishra SK, Tripathi S, de Alencar MVOB, E Sousa JM de C, et al. Mycotoxin-assisted mitochondrial dysfunction and cytotoxicity: Unexploited tools against proliferative disorders. IUBMB Life. 2018;70:1084–1092. doi: 10.1002/iub.1932. [DOI] [PubMed] [Google Scholar]
  • 77.Gallagher L, Owens RA, Dolan SK, O’Keeffe G, Schrettl M, et al. The Aspergillus fumigatus protein GliK protects against oxidative stress and is essential for gliotoxin biosynthesis. Eukaryot Cell. 2012;11:1226–1238. doi: 10.1128/EC.00113-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Schrettl M, Carberry S, Kavanagh K, Haas H, Jones GW, et al. Self-protection against gliotoxin--a component of the gliotoxin biosynthetic cluster, GliT, completely protects Aspergillus fumigatus against exogenous gliotoxin. PLoS Pathog. 2010;6:e1000952. doi: 10.1371/journal.ppat.1000952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Fang FC, Frawley ER, Tapscott T, Vázquez-Torres A. Bacterial stress responses during host infection. Cell Host Microbe. 2016;20:133–143. doi: 10.1016/j.chom.2016.07.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Abad A, Fernández-Molina JV, Bikandi J, Ramírez A, Margareto J, et al. What makes Aspergillus fumigatus a successful pathogen? Genes and molecules involved in invasive aspergillosis. Rev Iberoam Micol. 2010;27:155–182. doi: 10.1016/j.riam.2010.10.003. [DOI] [PubMed] [Google Scholar]
  • 81.Reichard U, Cole GT, Hill TW, Rüchel R, Monod M. Molecular characterization and influence on fungal development of ALP2, a novel serine proteinase from Aspergillus fumigatus . Int J Med Microbiol. 2000;290:549–558. doi: 10.1016/S1438-4221(00)80021-1. [DOI] [PubMed] [Google Scholar]
  • 82.Burgel P-R, Paugam A, Hubert D, Martin C. Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy. Infect Drug Resist. 2016;9:229–238. doi: 10.2147/IDR.S63621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Dagenais TRT, Keller NP. Pathogenesis of Aspergillus fumigatus in invasive Aspergillosis . Clin Microbiol Rev. 2009;22:447–465. doi: 10.1128/CMR.00055-08. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary material 1
Supplementary material 2

Articles from Microbiology are provided here courtesy of Microbiology Society

RESOURCES